37875143 37875143 Rha SY, Oh D‐Y, Yañez P et al (2023) Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial. The gene discussed is ERBB2; the disease is gastric cancer.